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Background. Yaws-like chronic ulcers can be caused by Treponema pallidum subspecies pertenue, Haemophilus ducreyi, or 
other, still-undefined bacteria. To permit accurate evaluation of yaws elimination efforts, programmatic use of molecular diagnostics 
is required. The accuracy and sensitivity of current tools remain unclear because our understanding of T. pallidum diversity is limited 
by the low number of sequenced genomes.
Methods. We tested samples from patients with suspected yaws collected in the Solomon Islands and Ghana. All samples were 
from patients whose lesions had previously tested negative using the Centers for Disease Control and Prevention (CDC) diagnostic 
assay in widespread use. However, some of these patients had positive serological assays for yaws on blood. We used direct whole-ge-
nome sequencing to identify T. pallidum subsp pertenue strains missed by the current assay.
Results. From 45 Solomon Islands and 27 Ghanaian samples, 11 were positive for T. pallidum DNA using the species-wide 
quantitative polymerase chain reaction (PCR) assay, from which we obtained 6 previously undetected T. pallidum subsp pertenue 
whole-genome sequences. These show that Solomon Islands sequences represent distinct T. pallidum subsp pertenue clades. These 
isolates were invisible to the CDC diagnostic PCR assay, due to sequence variation in the primer binding site.
Conclusions. Our data double the number of published T. pallidum subsp pertenue genomes. We show that Solomon Islands 
strains are undetectable by the PCR used in many studies and by health ministries. This assay is therefore not adequate for the eradi-
cation program. Next-generation genome sequence data are essential for these efforts.
Keywords. whole-genome sequencing; next-generation sequencing; yaws; Treponema pallidum. 
Yaws, caused by Treponema pallidum subspecies pertenue, is 
a major public health problem in many tropical countries [1]. 
The disease is most common in West Africa and the Pacific [2] 
and predominantly affects children living in remote commu-
nities. Primary yaws manifests as chronic painless cutaneous 
ulcers and papillomatous lesions that, if untreated, can progress 
to cause destructive lesions of bone and soft tissues. In 2012, 
azithromycin was shown to be a highly effective treatment for 
yaws [3], prompting a new World Health Organization (WHO) 
eradication strategy based on community mass treatment with 
azithromycin [4]. Initial pilot data suggest this is a powerful 
intervention for reducing transmission within communities [5].
Clinical diagnosis of yaws is unreliable and serological test-
ing is needed to confirm the diagnosis [1, 6, 7]. Serological tests 
cannot distinguish yaws from syphilis; this distinction relies on 
consideration of the clinical syndrome, epidemiology, or molec-
ular tools. In many settings, up to 50% of possible yaws lesions 
are not confirmed serologically [6, 8], reflecting the broad range 
of causes of skin ulcers in the tropics, with bacterial, fungal, and 
parasitic infections all being common differential diagnoses. For 
example, Haemophilus ducreyi has been found to be a common 
cause of chronic ulcerative skin lesions in yaws-endemic areas, 
and lesions caused by H. ducreyi are clinically indistinguishable 
from yaws [7, 9, 10]. Consequently, WHO recommends molec-
ular diagnostic tests as part of the case definition in yaws eradi-
cation efforts [11]. Molecular diagnostics are also used to detect 
mutations conferring azithromycin resistance [12] and are 
therefore a central component of the eradication strategy [11].
The genome sequences of T. pallidum subspecies are highly con-
served, with <0.2% of sequence variation between subspecies [13]. 
However, there are few complete sequences available to inform 
selection of molecular targets for polymerase chain reaction 
(PCR), in part due to our inability to culture T. pallidum in vitro. 
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Currently no multiplex assay exists for diagnosis of ulcerative 
skin lesions in the tropics, but a real-time PCR assay, targeting 
the tp0858 gene (a predicted outer membrane protein), has been 
developed to detect T. pallidum subsp pertenue and differenti-
ate it from other T. pallidum subspecies [8]; this PCR is here-
inafter referred to as the 2015 Centers for Disease Control and 
Prevention (CDC) real-time PCR assay. The assay is believed to 
have an analytical sensitivity of 10–100 copies per reaction [8]. 
An alternative approach is to combine a PCR assay targeting a 
pan-species T. pallidum target with secondary PCR for subspe-
cies confirmation [10], but currently the 2015 CDC real-time 
PCR assay is being used by health ministries to support yaws 
eradication efforts worldwide. When either of these assays is 
used, a minority of samples from yaws-like lesions is found to 
contain T. pallidum subsp pertenue DNA [7–10].
In a recent study in the Solomon Islands, for example, the 
seroprevalence of treponemal antibodies was >30% among 
children aged 5–14 years, and 2% of children in that age group 
had a skin lesion consistent with active yaws and reactive 
serological tests, yet no T.  pallidum subsp pertenue DNA was 
detected using the 2015 CDC real-time PCR assay [9]. Given 
the strong epidemiological, clinical, and serological evidence 
of yaws transmission in the Solomon Islands, we hypothesized 
that this molecular test failed to detect local T. pallidum subsp 
pertenue strains. The aim of this study was to use next-genera-
tion sequencing to explore the reasons why T. pallidum subsp 
pertenue was not detected using the 2015 CDC real-time PCR 
assay in samples from patients showing clinical and serological 
evidence of yaws, and to develop a modified assay capable of 
detecting these missed samples.
METHODS
Sample Collection
Samples were collected during surveys conducted in the 
Solomon Islands in 2013 and Ghana in 2014 [6, 7]. In brief, the 
survey in the Solomon Islands was a community-based cluster 
randomized prevalence survey, whereas the survey in Ghana 
used school-based recruitment. In both surveys, lesion swabs or 
lesion crusts were collected from individuals with chronic ulcer-
ative lesions clinically consistent with yaws. DNA was prepared 
from residual sample material from these 2 original surveys.
Data Collection
Clinical and demographic data for this study were limited to data 
collected in the original surveys [6, 7, 9], which included age, 
gender, lesion location, and serological results. In Ghana, ulcer 
samples had been collected directly onto dry Dacron swabs. In 
the Solomon Islands, swab exudate was placed either into trans-
port medium (AssayAssure, Sierra Molecular) or onto an FTA 
Elute Card (Whatman). In both studies, where lesion crusts were 
present, these were removed and placed in transport medium 
(AssayAssure). As part of the original surveys, all individuals had 
a serum sample tested using a T. pallidum particle agglutination 
assay and, when this was positive, a quantitative rapid plasma 
reagin assay [7, 9]. Lesion samples had been assayed with the 2015 
CDC real-time PCR assay for T. pallidum subsp pertenue [7] as part 
of the earlier studies, and the results were available for this study.
Sample Preparation
Following collection, samples were stored at –20°C in Ghana 
and the Solomon Islands, before being transported to the CDC 
on dry ice. Following this, samples were stored again at –20°C 
before being transported back to the London School of Hygiene 
and Tropical Medicine on dry ice for the current study. DNA 
was extracted from the residual sample material using the 
QIAamp Mini kit from Qiagen with variations (Supplementary 
Appendix 1). DNA preparations were screened for the presence 
of T.  pallidum using a quantitative PCR (qPCR) assay target-
ing the tp47 (tp0574) gene (hereafter “tp47-PCR”) that is con-
served in all known members of the T.  pallidum species, but 
which does not distinguish between T. pallidum subspecies [14, 
15]. For T. pallidum–positive samples, we used a DNA concen-
tration cutoff of 10 copies/μL to select samples likely to yield 
accurate whole genomes. Samples above this cutoff were sent 
for direct (non-culture-based) sequencing.
Whole-Genome Sequencing and Analysis
Treponema pallidum genomic DNA (gDNA) was quantified, 
per sample, and supplemented with human gDNA (Invitrogen) 
to make a final total DNA concentration of 500 ng. DNA sam-
ples were fragmented to an average size of 150 bp and subjected 
to DNA library creation using established Illumina paired-end 
protocols [16]. Adapter-ligated libraries were amplified and 
indexed via PCR. A  portion of each library was used to cre-
ate an equimolar DNA pool. Each pool was hybridized to cus-
tom-made SureSelect RNA baits (Agilent Technologies; baits 
based on all published sequences of T. pallidum and Treponema 
paraluiscuniculi genomes [17–19]) (Supplementary Appendix 
1). Targets were captured and amplified in accordance with 
manufacturer recommendations. Enriched libraries were sub-
jected to standard 75-bp paired-end sequencing (HiSeq 2000; 
Illumina) following manufacturer instructions. Samples’ public 
accession numbers are listed in Supplementary Table 1.
We used whole-genome sequencing (WGS) read data to esti-
mate phylogenies for T.  pallidum subsp pertenue: reads were 
mapped using SMALT [20] to the reference genome T. pallidum 
subsp pertenue strain Samoa D (EMBL CP002374 [21]). Single-
nucleotide polymorphisms (SNPs) were identified for each 
mapped sample using SamTools [22] with previously described 
settings [23]. Gubbins was used (with default settings; see 
Supplementary Appendix 1 for more details) to identify recombi-
nation blocks (defined by high SNP density) using the whole-ge-
nome SNP data of each sample as previously described [24]. 
SNPs in recombination blocks were excluded from phylogenetic 
analysis (all recombination blocks are listed in Supplementary 
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Table 2) as they do not represent the underlying phylogeny of the 
host (Figure 1). The remaining chromosomal SNPs from each iso-
late were used to generate a multiple alignment of concatenated 
SNPs for all isolates. Maximum likelihood phylogenetic trees were 
estimated using RAxML with a general time reversible site model, 
using gamma correction for among-site variation and 100 boot-
strap replicates [25]. De novo genome assemblies were performed 
as previously described [26] or using SPAdes [27]. Contigs were 
automatically annotated using in-house pipelines as previously 
described [28]. Default parameters for software packages are 
described in Supplementary Appendix 1. Genes of interest were 
identified and curated by hand in pairwise comparisons with the 
reference genome using ACT or Artemis [29]. Mapping and assem-
bly statistics are listed in Supplementary Table 1. Supplementary 
Table 1 also includes data for simulated reassemblies of the 2 refer-
ence sequences to determine the achievable reassembly size from 
Illumina 75-bp paired-end reads and the standard assembly pro-
tocols used in this study. The 75-bp paired-end reads were gener-
ated in silico from the reference genome using in-house scripts to 
simulate raw Illumina WGS data.
Development of a Modified PCR Assay
We used results of WGS to design a modified PCR assay tar-
geting the tp0858 gene. We designed 2 new reverse PCR prim-
ers with different lengths and annealing temperatures, denoted 
“modified PCR-1” (5ʹ-GTGCGGTGAGCCCGGCGTT-3ʹ) and 
“modified PCR-2” (5ʹ-GTGAGCCCGGCGTT-3ʹ). We tested 
the assay using both gDNA from a Solomon Islands sample 
(WP0022.7liq) and from a non–Solomon Islands sample (non-SI, 
strain Gauthier). Double-distilled water was used as a control. 
We selected the shorter modified PCR-2 reverse primer for a 
modified qPCR assay. We performed qPCR using the original 
forward and reverse (denoted “2015 CDC RT-PCR” in Figure 2) 
2015 CDC real-time PCR primers [8], as well as the original for-
ward primer plus the modified PCR-2 reverse primer (denoted 
“modified PCR-2” in Figure  2). We also used the forward 
primer plus both reverse primer variants together (Figure 3; for 
conditions, see Supplementary Appendix). The PCR was run 
on an Applied Biosystems StepOne Plus qPCR machine using 
the TaqMan Fast Advanced Master Mix. We used a probe that 
detects both Solomon Islands and non–Solomon Islands strains 
(5ʹ-FAM-GCTGCAAGGAGAAGTCCTGCTGC-TAMRA-3ʹ).
Ethics Approval
The studies were approved by the London School of Hygiene 
and Tropical Medicine, Solomon Islands National Health 
Research, and Kwame Nkrumah University of Science and 
Technology ethics committees.
RESULTS
Participants
Seventy-two residual samples taken from 63 people were included 
in this study [6, 7, 9] (Figure 1). The median age of participants in 
the original studies was 9 years (interquartile range, 7–11 years) 
and 36 contributing participants (57.1%) were male. Of samples 
recovered and tested here, 69 were collected from lesions located 
on the leg; lesion location was not recorded for 3 samples [6, 7, 9]. 
In the original studies [7, 9], none of the samples from either site 
Figure 1. Study flowchart. Samples were originally collected in 2 studies conducted in Ghana and the Solomon Islands. The results of Treponema pallidum particle agglu-
tination assays conducted in the original studies and of the tp47 polymerase chain reaction assay performed in this study are shown. Abbreviations: PCR, polymerase chain 
reaction; TPPA, Treponema pallidum particle agglutination.
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had tested positive for T. pallidum subsp pertenue using the 2015 
CDC real-time PCR assay, but 24 samples had tested positive for 
H. ducreyi using a 16S ribosomal RNA targeted PCR assay (15 
from the Solomon Islands and 9 from Ghana).
Using the screening tp47-PCR assay, 11 samples were shown 
to be positive for T. pallidum (Figure 1). In 10 tp47-PCR–posi-
tive samples from the Solomon Islands, the median T. pallidum 
chromosomal copy number was 1084/μL. The single Ghanaian 
sample that was T. pallidum positive using the tp47-PCR assay 
had the lowest T.  pallidum chromosomal copy number (~38/
μL) of any positive sample included in this study.
Direct WGS of T. pallidum subsp pertenue
From 11 T. pallidum–positive samples, 8 (72.7%) complete genomes 
of T. pallidum subsp pertenue were obtained. The 8 genomes were 
generated from samples taken from 6 individuals in the Solomon 
Islands, including 3 samples collected from the same individual 
(Supplementary Table 1). There was no evidence of sequence hete-
rozygosity in any of the Solomon Islands T. pallidum subsp pertenue 
genomes to indicate that any individual subject was simultaneously 
infected with multiple strains of T. pallidum subsp pertenue.
T. pallidum subsp pertenue Genome Analysis
Phylogenetic analysis demonstrated that T. pallidum subsp per-
tenue strains from the Solomon Islands form a discrete lineage 
that can be further subdivided into 2 distinct clades, both of 
which are distinct from all previously sequenced T.  pallidum 
subsp pertenue samples. Solomon Islands T. pallidum subsp per-
tenue genomes were highly conserved, separated by a maximum 
pairwise distance of <20 SNPs (Figure 2). There were no whole 
gene differences among the manually curated Solomon Islands 
genomes or when comparing the Solomon Islands genomes to 
the reference sequence (SamoaD strain) or to previously pub-
lished sequences. Three genomic regions were identified as 
recombinant in all, or a subset, of the Solomon Islands T. pal-
lidum subsp pertenue genomes (Figure  2). Thirteen recom-
binant regions were defined, across all subspecies included, 
due to their high SNP density (Figure  2 and Supplementary 
Figure 2. Phylogenetic tree of Treponema pallidum subspecies pertenue genomes. Phylogenetic tree of T. pallidum subsp pertenue sequences estimated by mapping to the 
T. pallidum subsp. pertenue SamoaD reference genome. Recombination blocks shared by 1 or more isolates are numbered and those unique to a single isolate are unnum-
bered. Vertical bars over the genome length (gray block) mark the location of the tpr genes. Coordinates are in base pairs with respect to the reference gnome. Recombination 
blocks present in the Solomon Islands T. pallidum subsp pertenue isolates are numbered (1–3; main frame). Recombination block 2 spans several genes (top right), including 
Tp_0858, which contains the primer-binding sites used in the 2015 Centers for Disease Control and Prevention (CDC) real-time polymerase chain reaction (PCR) assay. The 
positions of single-nucleotide polymorphisms identified in region 2 are shown for each isolate (top right) compared to the reference genome. Top left shows an alignment of 
the region of the reference genomes amplified by the 2015 CDC real-time PCR assay for T. pallidum subsp pertenue isolates compared to the same region in samples from 
the Solomon Islands. Primer binding sites are indicated by arrows. Several mutations within these sites are found in Solomon Islands samples. Abbreviations: CDC, Centers 
for Disease Control and Prevention; FP, forward primer; PCR, polymerase chain reaction; RP, reverse primer; SI, Solomon Islands; TPP, Treponema pallidum subsp pertenue.
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Table 2). Recombinant region 1 included the TPESAMD_0134 
gene predicted to encode a putative outer member protein 
[21] (sequence accession number CP002374). Region 2 was 
predicted to encode 10 genes and 2 gene remnants, including 
tp0858. Region 3 encompassed the tprK gene, which is known 
in T. pallidum subsp pallidum to undergo antigenic variation via 
segmental gene conversion. No 23S rDNA mutations known to 
confer resistance to azithromycin were found.
The increased SNP density found in region 2 included several 
variations within the 2015 CDC real-time PCR assay reverse prim-
er-binding site (within tp0858) for (Figure 2). The forward 2015 
CDC real-time PCR primer-binding site is conserved in all T. pal-
lidum subsp pertenue isolates (Figure 2). Although variation within 
tp0858 is seen when comparing the Solomon Islands T. pallidum 
subsp pertenue isolates’ sequences to the reference (Figure 2), this 
likely recombination block sequence is fixed and conserved in all 
of the Solomon Islands isolates we sequenced. This suggests that 
this sequence is representative of isolates circulating in the South 
Pacific. These data also provide an explanation as to why the 2015 
CDC real-time PCR assay had failed in this setting (Figure 3).
Modified PCR Assay
Using our modified PCR assay, we were able to amplify DNA 
from Solomon Islands samples (Figure  3A) and demonstrate 
that the Solomon Islands new reverse primer (but not the exist-
ing CDC real-time PCR reverse primers) detect T.  pallidum 
subsp pertenue samples from the Solomon Islands (Figure 3B). 
These data also show that these primers can be used success-
fully in combination (Figure 3).
DISCUSSION
In this study we aimed to explain why, in a country endemic 
for yaws, all previously tested samples had tested negative for 
T. pallidum subsp pertenue DNA using the standard 2015 CDC 
real-time PCR assay [9]. We identified a large number of T. pal-
lidum subsp pertenue positive samples that were missed using 
Figure 3. Gel and quantitative polymerase chain reaction (PCR) assays utilizing both existing and new PCR primers. A, Gel picture showing PCR products for the genomic DNA 
(gDNA) of a Solomon Islands (SI) sample WP0022.7liq, and a non-SI sample, Treponema pallidum subsp pertenue Gauthier, with the use of the generic forward and reverse primers 
as indicated. The reverse primer of the Centers for Disease Control and Prevention (CDC) 2015 real-time (RT) PCR assay is labeled reverse primer in Figure 2 . Forward primer 
(2015 CDC RT-PCR): 5ʹ-CGGCCACCAACTTGGGATTGAC-3ʹ. Reverse primer (2015 CDC RT-PCR): 5ʹ-CGTACACCGAACCTTTGTCTT-3ʹ. Reverse primer (modified PCR-1): 5ʹ- GTGCG-
GTGAGCCCGGCGTT-3ʹ. Reverse primer (modified PCR-2): 5ʹ-GTGAGCCCGGCGTT-3ʹ. B, Quantitative PCR amplification curves of new PCR products obtained for the gDNA of the 
non-SI sample, an SI sample, and both samples (all as in A) combined by using specific reverse primers. Forward primer (2015 CDC RT-PCR): 5ʹ-CGGCCACCAACTTGGGATTGAC-3ʹ. 
Probe: 5ʹ-FAM-GCTGCAAGGAGAAGTCCTGCTGC-TAMRA-3ʹ. Reverse primer (2015 CDC real-time PCR): 5ʹ-CGTACACCGAACCTTTGTCTT-3ʹ. Reverse primer (modified  PCR-2): 
5ʹ-GTGAGCCCGGCGTT-3ʹ. Abbreviations: ∆Rn, normalized reporter signal; CDC, Centers for Disease Control and Prevention; DDW, double distilled water; RT-PCR, real-time 
polymerase chain reaction; SI, Solomon Islands.
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the 2015 CDC real-time PCR assay. These all demonstrated 
mutations in the PCR primer-binding sites targeted by that 
assay. PCR of these samples was negative when the 2015 CDC 
real-time PCR primers were used but positive for T. pallidum 
subsp pertenue using a modified assay based on the sequence 
data generated in this study (Figure 3). Overall, 22% of samples 
from the Solomon Islands were positive using our approach, a 
proportion comparable to that seen in other studies in Papua 
New Guinea and Vanuatu [8, 10]. The current data call in to 
question the validity of the finding that many yaws-like lesions 
are negative on molecular testing using the 2015 CDC real-time 
PCR assay [7–10]. It is plausible that next-generation sequenc-
ing might identify further T.  pallidum subsp pertenue strains 
from other contexts that test negative by the 2015 CDC real-
time PCR assay.
Because lesions caused by a variety of other bacteria appear 
clinically similar to yaws, molecular diagnostics have become 
key to the case definition in yaws eradication programs [11]. The 
findings presented here demonstrate that the 2015 CDC real-
time PCR assay does not detect all T. pallidum subsp pertenue 
isolates. Given our findings, it may be technically challenging 
to design a single-target T.  pallidum subsp pertenue–specific 
PCR. We believe a strategy using a PCR that targets conserved 
regions of T. pallidum would be more appropriate and less prone 
to false-negative results. If required, additional testing using a 
panel of PCR assays for subspecies-level identification could 
be performed (eg, in cases of genital lesions or older individ-
uals where syphilis is a differential diagnosis). Assays suitable 
for this approach exist [10], although it is not certain that they 
will not also miss as-yet-unrecognized T. pallidum subsp per-
tenue strains were variation to exist in the tp47 gene targeted by 
the screening PCR. Sequencing of a larger number of samples 
would help confirm that the tp47 gene is highly conserved and 
therefore a suitable target for screening PCR.
Understanding of treponemal diversity has been severely 
hampered by our inability to culture T. pallidum in vitro. The 
direct sequencing techniques used in this study may provide 
insights into unanswered questions about yaws. The yaws clin-
ical phenotype varies between West Africa, where papillomatous 
lesions predominate, and the Pacific, where ulcerative lesions 
are more common. Next-generation sequencing may help to 
reveal contributing causes. Even in the absence of known muta-
tions associated with azithromycin resistance, some patients do 
not experience cure following treatment. The techniques used 
in this study may allow characterization of pathogen factors 
associated with outcome. Multicountry studies to explore these 
questions are warranted.
Although the T. pallidum subspecies that cause syphilis and 
yaws are extremely closely related [13], the phenotypes of the 
diseases differ. There is limited understanding of the factors 
driving observed differences in tropism and virulence between 
subspecies. Neurological and cardiovascular manifestations are 
classical features of tertiary syphilis, yet are seen in a minority 
of untreated patients. These severe clinical manifestations are 
generally believed to be absent in yaws, although older stud-
ies in Ghana noted that cardiovascular manifestations might 
occasionally present [30], and some studies have suggested that 
neurological manifestations and congenital transmission may 
occur in yaws [31]. Examination of larger numbers of trepone-
mal genomes by direct sequencing might help us understand 
the difference in outcomes of these infections.
A limitation of our study is the relatively small number 
of samples sequenced. However, the T.  pallidum subsp per-
tenue genome sequences obtained in this study double the 
total number of described sequences available, including data 
from all previous studies and have provided new insights 
into T.  pallidum subsp pertenue diversity and the design of 
molecular diagnostics. It is possible that repeat freeze-thaw-
ing and use of residual sample may have limited the amount 
of genomic material available for sequencing in the current 
study. One sample from Ghana had a positive tp47-PCR assay 
despite negative serology. Although the overall chromosomal 
copy number was low, we believe this is consistent with early 
active yaws before a serological response has occurred (analo-
gous to early syphilis).
In this study, we demonstrate the clinical and public health 
value of next-generation sequencing techniques in yaws. 
These techniques could provide valuable data on the etiology 
of yaws and yaws-like lesions. We identified a high propor-
tion of lesions containing a new strain of T. pallidum subsp 
pertenue undetectable by the 2015 CDC real-time PCR assay. 
Importantly, our findings demonstrate that this assay will 
not be adequate for use in yaws eradication efforts. Urgent 
steps are needed to improve our understanding of T. pallidum 
subsp pertenue diversity worldwide, to ensure molecular 
diagnostics are program ready.
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